July 15, 2022
Meiogenix is pleased to announce that Dr. Neal Gutterson has joined the Meiogenix Board of Directors. Meiogenix’ board chair Johan Cardoen welcomes Dr. Gutterson, noting “Neal has been a very impactful leader in the ag industry, with a strong expertise in biotechnology and genomics. He has been a champion of genome editing and other advanced molecular breeding tools to create new value for farmers and consumers. We look forward to his strategic insights for the Meiogenix board”.
March 17, 2022
Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, has joined Cornell’s McGovern Center business. The Meiogenix U.S. operation will have access to Cornell academic and research resources to focus on advancing tomatoes and other field crops.
December 14, 2021
Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced today the closing of a $13 million (€11 million) Series A financing round, led by Sofinnova Partners, with participation from Genoa Ventures, Bpifrance, Casdin Capital and Alexandria Venture Investments.
February 19, 2020
A Cornell professor is collaborating with European partners to engineer maize – the largest staple crop in the world – with desirable traits, from resistance to disease to climate resilience. Wojtek Pawlowski, associate professor of plant genetics, has been studying the mechanisms of genetic recombination for 15 years.
Bayer, Meiogenix collaborate to accelerate agricultural innovation through the development of unique technologies
February 10, 2020
Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breeding and genome editing applications.